Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Should Expectations About The Rate Of New Antiretroviral Drug Development Impact The Timing Of Hiv Treatment Initiation And Expectations About Treatment Benefits?, Amin Khademi, R. Scott Braithwaite, Denis Saure, Andrew J. Schaefer, Kimberly Nucifora, Mark S. Roberts
Should Expectations About The Rate Of New Antiretroviral Drug Development Impact The Timing Of Hiv Treatment Initiation And Expectations About Treatment Benefits?, Amin Khademi, R. Scott Braithwaite, Denis Saure, Andrew J. Schaefer, Kimberly Nucifora, Mark S. Roberts
Amin Khademi
Background: Many analyses of HIV treatment decisions assume a fixed formulary of HIV drugs. However, new drugs are approved nearly twice a year, and the rate of availability of new drugs may affect treatment decisions, particularly when to initiate antiretroviral therapy (ART).
Objectives: To determine the impact of considering the availability of new drugs on the optimal initiation criteria for ART and outcomes in patients with HIV/AIDS.
Methods: We enhanced a previously described simulation model of the optimal time to initiate ART to incorporate the rate of availability of new antiviral drugs. We assumed that the future rate of availability …